Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer is a research paper published in Nature Communications (2024). On theSindex it has a DataRank of 0.464. It has been cited 16 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.0393
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
Foundation for the National Institutes of Health
Grant: R01CA246765
Foundation for the National Institutes of Health
Grant: R01CA277857
Foundation for the National Institutes of Health
Grant: R50CA283476
Foundation for the National Institutes of Health
Grant: R50CA265332
NCI NIH HHS
Grant: R01 CA230913
NCI NIH HHS
Grant: R01 CA274963
NIGMS NIH HHS
Grant: R01 GM135362
NCI NIH HHS
Grant: R01 CA234162
NCI NIH HHS
Grant: R01 CA275846
NCI NIH HHS
Grant: P50 CA211024
NCI NIH HHS
Grant: R01 CA276308
NCI NIH HHS
Grant: U24 CA274159
NCI NIH HHS
Grant: R01 CA265892
NCI NIH HHS
Grant: R37 CA230617
NCI NIH HHS
Grant: K22 CA269707
NCI NIH HHS
Grant: R01 CA250025
National Institutes of Health
Grant: 5R01CA265892-04
Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer
National Institutes of Health
Grant: 1R01CA230913-01A1
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer
National Institutes of Health
Grant: 5R37CA230617-03
Hormone signaling and translation control in advanced prostate cancer
National Institutes of Health
Grant: 5R01CA277857-02
Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
National Institutes of Health
Grant: 5R50CA265332-04
Dissecting the in vivo stromal metabolic and inflammatory crosstalk in colorectal cancer
National Institutes of Health
Grant: 5R01GM135362-04
Selective mRNA translation in developmental disorders
National Institutes of Health
Grant: 5R01CA276308-03
Transcriptional-translational conflict in bladder epithelial homeostasis and cancer
National Institutes of Health
Grant: 5R50CA283476-02
Molecular mechanisms driving therapy-induced lineage plasticity
National Institutes of Health
Grant: 5R01CA246765-03
Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate Cancer
National Institutes of Health
Grant: 5R01CA250025-03
Molecular mechanisms driving mesenchymal colorectal cancer
National Institutes of Health
Grant: 1P50CA211024-01A1
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
National Institutes of Health
Grant: 5R01CA275846-03
Cholesterol metabolism in mesenchymal colorectal cancer
Fields of Study
MeSH Terms
Keywords